This announcement is a separate document:
福建傲农生物科技集团股份有限公司关于收到上海证券交易所对公司2023年年度报告的信息披露监管问询函的公告
Announcement of Fujian Aonong Biotechnology Group Co., Ltd. on receiving an information disclosure regulatory inquiry letter from the Shanghai Stock Exchange on the company's 2023 annual report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.